Lv3
400 积分 2022-01-04 加入
A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients
11天前
已完结
Daclizumab, an efficient treatment for steroid‐refractory acute graft‐versus‐host disease
13天前
已完结
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
13天前
已关闭
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
13天前
已关闭
Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab
13天前
已完结
Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab
13天前
已完结
Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab
13天前
已完结
Improved survival in steroid‐refractory acute graft versus host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis
13天前
已完结
Daclizumab for children with corticosteroid refractory graft-versus-host disease
13天前
已完结
Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients
13天前
已完结
皖公网安备34019202002308
